Injective (INJ) is currently priced at $3.66, reflecting a 5.54% increase over the last 24 hours, which is a positive signal for short-term traders. The price has fluctuated between $3.40 and $4.00 during this period, indicating a healthy daily range of 0.6%.

The trading volume of 158,442,577 represents 43.26% of its market cap, suggesting robust market activity and interest in INJ. The hourly moving averages show mixed signals, with the 55 SMA indicating a bullish trend (+5.31%) while the shorter SMAs indicate bearish momentum, particularly the 8 SMA at $3.79 (-3.37%) and 13 SMA at $3.82 (-4.23%).

The 1-hour RSI is at 42, suggesting that INJ is approaching oversold conditions, while the 7-day RSI at 55 indicates a neutral stance. Over the past week, INJ has appreciated by 12.34%, demonstrating a strong recovery compared to the 30-day decline of -20.88%, indicating potential for a trend reversal.

Despite the recent gains, the current price is significantly lower than its all-time high of $52.62, suggesting that there is considerable room for growth if market conditions stabilize. However, the mixed signals from moving averages and the RSI suggest caution, as volatility may persist in the short term.

Given the current analysis, a "Hold" rating is recommended. The recent positive momentum is encouraging, but the underlying volatility and mixed technical indicators warrant careful observation before making a bullish stance.